| 发明名称 |
Methods of treating immune disorders with single domain antibodies against TNF-alpha |
| 摘要 |
The invention relates to the TNFX binding molecule ozoralizumab (ATN-103), methods of using this molecule to treat immune disorders, including rheumatoid arthritis, and specific dosing regimens for the treatment of rheumatoid arthritis. |
| 申请公布号 |
AU2012237287(B2) |
申请公布日期 |
2016.09.08 |
| 申请号 |
AU20120237287 |
申请日期 |
2012.03.30 |
| 申请人 |
ABLYNX NV |
发明人 |
HEGEN, MARTIN;COMER, GAIL;SHARMA, AMARNATH;SHIELDS, KATHY |
| 分类号 |
C07K16/18;A61K39/395;A61P19/02;A61P37/06;C07K16/24;C07K16/46 |
主分类号 |
C07K16/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
